Global Needle-free Diabetes Care Market Size study, by Devices Types (Treatment Devices, Diagnostic Devices) by Treatment (Oral Insulin, Inhaled Insulin, Insulin Patch, Others) by Application (Insulin Delivery, Other), by End Users (Diagnostic Centers, Hospitals & Clinics, Other) and Regional Forecasts 2022-2028Global Needle-free Diabetes Care Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Needle-free Diabetes Care is a cutting-edge technology that is currently being developed. And this device will allow the people with diabetes to measure the level of blood sugar without having to stick needed in the fingertip. Continuous glucose monitors and insulin pumps are the finest choices available today for automating the majority of the complicated daily process of blood sugar management. The increasing prevalence of diabetes, increasing geriatric population and strategic development between hospitals has led the adoption of Needle-free Diabetes Care across the forecast period. According to International Diabetes Federation, total adult population in Spain is 34,538,600 in year 2020 and around 10.5 % of this had diabetes that is 3,619,100 adults had diabetes. Also, with the increasing prevalence of geriatric population, the adoption & demand for Needle-free Diabetes Care is likely to increase the market growth during the forecast period. However, high cost associated with the facility impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Needle-free Diabetes Care Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Because of the huge diabetic population, changing lifestyles, rising healthcare costs, and an increase in the number of obese persons, North America dominates the Needle-free Diabetes Care industry. Because of the increasing government funding for diabetes management in the region, Asia-Pacific is predicted to expand at the quickest rate throughout the forecast period of 2022 to 2028.

Major market player included in this report are:
Bioject Medical Technologies Inc.
Valeritas, Inc.
Antares Pharma
Endo International plc
InsuJet
PharmaJet
PenJet
INJEX
Technologies Medicales Internationales (MIT Canada) Inc.
Needle Free Injection System

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Devices Types:
Treatment Devices
Diagnostic Devices
By Treatment:
Oral Insulin
Inhaled Insulin
Insulin Patch
Others
By Application:
Insulin Delivery
Other
By End Users:
Diagnostic Centers
Hospitals & Clinics
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028

Target Audience of the Global Needle-free Diabetes Care Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Bioject Medical Technologies Inc.
Valeritas, Inc.
Antares Pharma
Endo International plc
InsuJet
PharmaJet
PenJet
INJEX
Technologies Medicales Internationales (MIT Canada) Inc.
Needle Free Injection System